自然環境における神経発達障害のある子供に対する EXPLORER 外骨格の有効性と使用性
Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. EXPLORER is a robotic gait exoskeleton designed to rehabilitate children with motor disabilities in home and outdoor environments.
The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.
調査の概要
詳細な説明
Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. Robotic devices are a useful tool in the rehabilitation of these children, but most of them are designed to be used in the clinical setting. EXPLORER is a robotic device designed to assist gait in children with motor disability in their homes and the community. The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.
An initial session will be conducted in the participant's natural environment, during which the researchers will instruct the primary caregivers on the use of the device. Subsequently, the device will be left for a two-month period for use in the natural settings deemed appropriate by the family.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Madrid
-
Alcorcón、Madrid、スペイン、28922
- Universidad Rey Juan Carlos
-
Madrid、Madrid、スペイン、28046
- Hospital Universitario La Paz
-
Madrid、Madrid、スペイン、28009
- Hospital Infantil Universitario Niño Jesús-Servicio de Neuro Ortopedia
-
Madrid、Madrid、スペイン、28007
- Hospital Universitario Gregorio Marañón
-
Madrid、Madrid、スペイン、28009
- Hospital Infantil Universitario Niño Jesús - Servicio de Rehabilitación
-
Madrid、Madrid、スペイン、28041
- Hospital Universitario 12 Octubre
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Diagnosis of any pathology or condition causing neurodevelopmental disorders.
- Ability to continuously use the device for two weeks, at least 3 times per week, without causing excessive fatigue that would prevent the participant from carrying out their usual activities.
- Availability and commitment from the family to use the device at least 3 times per week during the planned period, in different environments and with various objectives.
- Medical authorization for standing, gait training and weight bearing.
- Informed consent signed by legal guardians.
- Maximum user weight of 60 kg.
- Hip width (between greater trochanters) ≤37 cm.
- Length of the thigh (distance from the greater trochanter to the lateral condyle of the tibia) from 21cm to 36cm.
- Tibia leg length (distance from the lateral condyle of the tibia to the lateral malleolus) from 20cm to 35cm.
- Shoe size ≤40 (EU)
Exclusion Criteria:
- Medical contraindications for standing or walking.
- Non-reducible contractures or heterotropic ossifications above the degrees allowed by the device or out of the trajectory imposed by the device
- Spasticity equal to 4 on the Modified Ashworth Scale at the time of use of the device.
- More than 20º of hip and/or knee non-reducible contractures at the time of using the exoskeleton.
- Necessity to walk with more than 5º of hip abduction.
- Impossibility to reach 5º of ankle dorsiflexion with ir without orthoses.
- Lower length dysmetria that cannot be mitigated with a wedge under the foot.
- Skin lesion on parts of the lower extremities that are in contact with the device.
- History of fracture without trauma.
- Presence of other conditions causing exercise intolerance (such as uncontrolled hypertension, coronary artery disease, arrhythmia, congestive heart failure, severe pulmonary disease).
- Conductual disorders that may interfere with the use of the device or their participation in the study, like impulsiveness.
- Allergy to any of the EXPLORER materials: cotton, nylon, polyester, PPS, PEEK or ABS.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:EXPLORER
Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family. |
Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Serious Adverse Events
時間枠:through study completion, along 2 weeks
|
occurrence of any serious adverse event to the participant or the caregiver |
through study completion, along 2 weeks
|
|
Falls prevalence
時間枠:through study completion, along 2 weeks
|
Number of falling events occurred from the participant or caregiver |
through study completion, along 2 weeks
|
|
Skin integrity
時間枠:through study completion, along 2 weeks
|
Occurrence of any injury of the skin in the areas of contact and produced by the use of the device |
through study completion, along 2 weeks
|
|
Pain (Visual Analogic Scale)
時間枠:through study completion, along 2 weeks
|
pain measured by the Visual Analogic Scale (VAS) by the participant and the caregiver, scored from 0 to 10, being 0 "no pain" and 10 "unbearable pain" |
through study completion, along 2 weeks
|
|
Donning and doffing time
時間枠:through study completion, along 2 weeks
|
Time to don and doff the device to each participant |
through study completion, along 2 weeks
|
|
Device usage time
時間枠:through study completion, along 2 weeks
|
Time using the device |
through study completion, along 2 weeks
|
|
Number of steps
時間枠:through study completion, along 2 weeks
|
number of steps with the device |
through study completion, along 2 weeks
|
|
Usage modes
時間枠:through study completion, along 2 weeks
|
two different usage modes (active and automatic). |
through study completion, along 2 weeks
|
|
Speed
時間枠:through study completion, along 2 weeks
|
speed achieved with the device (steps per minute) |
through study completion, along 2 weeks
|
|
Device accessibility
時間枠:through study completion, along 2 weeks
|
Environments where the device has been used and level of accessibility in each environment measured with a 5 points Likert scale (0 not accessible - 5 very accessible) |
through study completion, along 2 weeks
|
|
Range of motion
時間枠:Before starting the intervention (S1) and after completing the two weeks of use
|
Passive Degree to which a joint can move (hip, knee, and ankle joints in both legs). From 0º to 180º. |
Before starting the intervention (S1) and after completing the two weeks of use
|
|
Participation
時間枠:Before starting the intervention (S1) and after completing the two weeks of use
|
Measured with the Child and Adolescent Scale of Participation. 20 ordinal scaled items across 4 subsections. Maximum total score is 80 (20 items x 4) and the minimum total score is 20 (20 items x 1) |
Before starting the intervention (S1) and after completing the two weeks of use
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
QUEST
時間枠:at the end of the intervention
|
Using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) questionnaire administered to the participants' caregivers at the end of the intervention. The QUEST 2.0 scale has 12 items. Each item is rated on a 5-point Likert scale |
at the end of the intervention
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。